Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Harvard Business School
Johnson and Johnson

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,877,192

« Back to Dashboard

Summary for Patent: 5,877,192

Title: Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
Abstract:A method for treatment of gastric acid related diseases by inhibition of gastric acid secretion comprising administering to a mammal in need of treatment a therapeutically effective amount of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benz imidazole or a pharmaceutically acceptable salt thereof, so as to effect decreased interindividual variation in plasma levels upon administration. The use of the (-)-enantiomer of omeprazole to receive increased average plasma levels (AUC) upon administration of the same doses of the (-)-enantiomer of omeprazole compared to those of racemic omeprazole is also claimed, as well as an improved antisecretory effect and a better clinical effect.
Inventor(s): Lindberg; Per (Molndal, SE), Weidolf; Lars (Vastra Frolunda, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/833,962
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,877,192

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9301830May 28, 1993
Sweden9601383Apr 11, 1996

International Patent Family for Patent: 5,877,192

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
CroatiaP940307► Subscribe
Hong Kong1028044► Subscribe
Hong Kong1028045► Subscribe
European Patent Office1020461► SubscribeC300482Netherlands► Subscribe
European Patent Office1020461► Subscribe91870Luxembourg► Subscribe
Spain2326404► Subscribe
Spain2326405► Subscribe
Finland950377► Subscribe
Spain2099047► Subscribe
European Patent Office1020460► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus